Ismail Kola
Director/Board Member presso Forepont Capital LLC
Patrimonio netto: 723 $ in data 29/02/2024
Profilo
Presently, Ismail Kola holds the position of Partner, Science & Vice Chairman at Forepont Capital LLC.
Dr. Kola is also Executive VP & President-New Medicines at UCB Pharma Oy Finland and on the board of 5 other companies.
In his past career he was Chairman of Athersys, Inc., Senior Vice President & Site Head-Basic Research at Merck & Co., Inc. Chief Scientific Officer for Schering-Plough Corp.
and Senior Vice President-Discovery Research at Schering-Plough Research Institute (both are subsidiaries of Merck & Co., Inc.), President-New Medicines, CSO & Executive VP at UCB SA, VP-Research & Global Head-Genomics Science at Pharmacia Corp.
and Professor-Human Molecular Genetics at Monash University.
Ismail Kola received a doctorate from the University of Cape Town, an undergraduate degree from the University of South Africa and an undergraduate degree from Rhodes University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ATHERSYS, INC.
0.10% | 14/08/2023 | 60 226 ( 0.10% ) | 723 $ | 29/02/2024 |
Posizioni attive di Ismail Kola
Società | Posizione | Inizio |
---|---|---|
UCB Pharma Oy Finland | Corporate Officer/Principal | - |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France. | Director/Board Member | 28/03/2019 |
Infinion Biopharma Ltd.
Infinion Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Infinion Biopharma Ltd. manufactures and sells pharmaceutical products. It is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. Infinion has set up a global network of subsidiaries and portfolio companies focused on edge technologies across the health care spectrum including: Process Technology, Biotechnology, Formuation Technology. The company was founded on January 16, 2018 and is headquartered in Ahmedabad, India. | Director/Board Member | 01/06/2018 |
GPN Vaccines Ltd.
GPN Vaccines Ltd. BiotechnologyHealth Technology GPN Vaccines Ltd. is an Australian biotechnology company that is developing a vaccine called Gamma-PN™ to protect against all strains of Streptococcus pneumoniae, which causes life-threatening pneumonia, bacteremia, meningitis, and middle ear infections. The company is based in Adelaide, Australia, and Tim Hirst has been the CEO since 2017. This disease is responsible for causing 1-2 million deaths worldwide each year, particularly in children. | Director/Board Member | - |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Director/Board Member | 07/11/2022 |
Invicta Medical, Inc.
Invicta Medical, Inc. Medical SpecialtiesHealth Technology Invicta Medical, Inc. operates as a medical technology company that develops wearable device for treatment of sleep apnea and snoring. Its device detects and treats disturbed breathing through electrical stimulation. The company was founded by Steven T. Kent and Harold Kent in 2013 and is headquartered in Portola Valley, CA. | Director/Board Member | 01/01/2022 |
BeCareLink | Director/Board Member | 01/01/2022 |
Precedenti posizioni note di Ismail Kola
Società | Posizione | Fine |
---|---|---|
ATHERSYS, INC. | Chairman | 28/09/2023 |
Mobius Medical Systems LP
Mobius Medical Systems LP Packaged SoftwareTechnology Services Mobius Medical Systems LP provides software solutions to clinicians. Its products include Mobius3D and DoseLab. The firm specializes in radiation oncology QA, IMRT QA and TG - 142. The company was founded by Nathan Childress in 2010 and is headquartered in Houston, TX. | Director/Board Member | 01/10/2021 |
░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Ismail Kola
University of Cape Town | Doctorate Degree |
University of South Africa | Undergraduate Degree |
Rhodes University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
UCB | Health Technology |
ATHERSYS, INC. | Health Technology |
Aziende private | 19 |
---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Health Technology |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Synosia Therapeutics develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. The firm is working to extend the reach of marketed and clinical-stage compounds, acquired through strategic partnerships with Novartis, Roche and Syngenta, into new indications with significant potential. Founded in December 2005 and headquartered in Switzerland, Synosia is managed by a highly experienced management team with some 200 years of drug development experience. The company is backed by $62 million in funding from high-quality investors and has a rich portfolio of compounds. | Health Technology |
Biotie Therapies Oy
Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
Promega Corp.
Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
UCB Pharma Oy Finland | |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
Ondek Pty Ltd.
Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Health Technology |
Invicta Medical, Inc.
Invicta Medical, Inc. Medical SpecialtiesHealth Technology Invicta Medical, Inc. operates as a medical technology company that develops wearable device for treatment of sleep apnea and snoring. Its device detects and treats disturbed breathing through electrical stimulation. The company was founded by Steven T. Kent and Harold Kent in 2013 and is headquartered in Portola Valley, CA. | Health Technology |
Biotie Therapies, Inc. | |
Mobius Medical Systems LP
Mobius Medical Systems LP Packaged SoftwareTechnology Services Mobius Medical Systems LP provides software solutions to clinicians. Its products include Mobius3D and DoseLab. The firm specializes in radiation oncology QA, IMRT QA and TG - 142. The company was founded by Nathan Childress in 2010 and is headquartered in Houston, TX. | Technology Services |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France. | Finance |
Infinion Biopharma Ltd.
Infinion Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Infinion Biopharma Ltd. manufactures and sells pharmaceutical products. It is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. Infinion has set up a global network of subsidiaries and portfolio companies focused on edge technologies across the health care spectrum including: Process Technology, Biotechnology, Formuation Technology. The company was founded on January 16, 2018 and is headquartered in Ahmedabad, India. | Health Technology |
GPN Vaccines Ltd.
GPN Vaccines Ltd. BiotechnologyHealth Technology GPN Vaccines Ltd. is an Australian biotechnology company that is developing a vaccine called Gamma-PN™ to protect against all strains of Streptococcus pneumoniae, which causes life-threatening pneumonia, bacteremia, meningitis, and middle ear infections. The company is based in Adelaide, Australia, and Tim Hirst has been the CEO since 2017. This disease is responsible for causing 1-2 million deaths worldwide each year, particularly in children. | Health Technology |
BeCareLink |